The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kozako, T.
Right arrow Articles by Sonoda, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kozako, T.
Right arrow Articles by Sonoda, S.
The Journal of Immunology, 2006, 177: 5718-5726.
Copyright © 2006 by The American Association of Immunologists, Inc.

Reduced Frequency, Diversity, and Function of Human T Cell Leukemia Virus Type 1-Specific CD8+ T Cell in Adult T Cell Leukemia Patients1

Tomohiro Kozako*, Naomichi Arima2,*, Shingo Toji, Izumi Masamoto*, Masaki Akimoto*, Heiichiro Hamada{ddagger}, Xiao-Fang Che§, Hiroshi Fujiwara{ddagger}, Kakushi Matsushita{ddagger}, Masahito Tokunaga*, Koichi Haraguchi*, Kimiharu Uozumi*, Susumu Suzuki{dagger}, Toshiro Takezaki{dagger} and Shunro Sonoda{dagger}

* Division of Host Response, Center for Chronic Viral Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University; {dagger} International Island and Community Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University; {ddagger} Department of Hematology and Immunology, Kagoshima University Hospital, and § Department of Molecular Oncology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan; and Medical and Biological Laboratories, Co., Ltd, Nagoya, Japan

Human T cell lymphotropic virus type 1 (HTLV-1)-specific CTL are thought to be immune effectors that reduce the risk of adult T cell leukemia (ATL). However, in vivo conditions of anti-HTLV-1 CTL before and after ATL development have yet to be determined. To characterize anti-HTLV-1 CTL in asymptomatic HTLV-1 carriers (AC) and ATL patients, we analyzed the frequency and diversity of HTLV-1-specific CD8+ T cells in PBMC of 35 AC and 32 ATL patients using 16 distinct epitopes of HTLV-1 Tax or Env/HLA tetramers along with intracellular cytolytic effector molecules (IFN-{gamma}, perforin, and granzyme B). Overall frequency of subjects possessing Tax-specific CD8+ T cells was significantly lower in ATL than AC (53 vs 90%; p = 0.001), whereas the difference in Env-specific CD8+ T cells was not statistically significant. AC possessed Tax11–19/HLA-A*0201-specific tetramer+ cells by 90% and Tax301–309/HLA-A*2402-specific tetramer+ cells by 92%. Some AC recognized more than one epitope. In contrast, ATL recognized only Tax11–19 with HLA-A*0201 and Tax301–309 with HLA-A*2402 at frequencies of 30 and 55%. There were also significant differences in percentage of cells binding Tax11–19/HLA-A*0201 and Tax301–309/HLA-A*2402 tetramers between AC and ATL. Anti-HTLV-1 Tax CD8+ T cells in AC and ATL produced IFN-{gamma} in response to Tax. In contrast, perforin and granzyme B expression in anti-HTLV-1 CD8+ T cells of ATL was significant lower than that of AC. Frequency of Tax-specific CD8+ T cells in AC was related to proviral load in HLA-A*0201. These results suggest that decreased frequency, diversity, and function of anti-HTLV-1 Tax CD8+ T cell clones may be one of the risks of ATL development.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This study was supported in part by Grants-in-Aid for Scientific Research on Priority Area for Cancer Research (122198232 and 12218104) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.

2 Address correspondence and reprint requests to Dr. Naomichi Arima, Division of Host Response, Center for Chronic Viral Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8544, Japan. E-mail address: nao{at}m2.kufm.kagoshima-u.ac.jp

3 Abbreviations used in this paper: ATL, adult T cell leukemia; HTLV-1, human T cell lymphotropic virus type 1; AC, asymptomatic HTLV-1 carrier; 7-AAD, 7-amino-actinomycin D.




This article has been cited by other articles:


Home page
BloodHome page
Y. Enose-Akahata, U. Oh, C. Grant, and S. Jacobson
Retrovirally induced CTL degranulation mediated by IL-15 expression and infection of mononuclear phagocytes in patients with HTLV-I-associated neurologic disease
Blood, September 15, 2008; 112(6): 2400 - 2410.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.